Biocon Limited has received approval from the South African Health Products Regulatory Authority (SAHPRA) for its vertically integrated, complex drug product Tacrolimus capsule 0.5mg, 1mg and 5mg strengths, in South Africa. This is the Company's first approval in this Country.
Amneal recently announced the appointment of Sandeep Raktate as its President-Operations, India & Ireland. The company also informed that Raktate and his team will be focused on advancing the company’s manufacturing of top quality, complex medicines.
The Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC-CCMB), a premier bio-incubator in Hyderabad, has signed an agreement with Thermo Fisher Scientific. The agreement includes equipping AIC-CCMB’s state-of-the-art facility, the Centre for Innovation, with cutting-edge technology to enable scientists in start-ups with opportunities to enhance their expertise and entrepreneurial acumen.
Shilpa Medicare’s marketing partner, Amneal Pharmaceuticals, has launched PEMRYDI RTU (Pemetrexed injection 10 mg/mL), the first ready-to-use pemetrexed formulation in the US market. The product has already been granted permanent J-code (J9324) by U.S. Centers for Medicare & Medicaid Services (CMS).
The US Food and Drug Administration (US FDA) has released a detailed report on six observations it reported following a recent inspection at Sun Pharmaceutical Industries plant in Dadra.
Aurigene Pharmaceutical Services Ltd., a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche small-molecule drug discovery service provider specialized in DNA encoded library (DEL) technologies, have partnered to co-market and offer DEL screening technologies to global customers as a standalone service or as an integrated drug discovery service.
19 Apr, 2024 Alzheon's oral anti-amyloid drug has potential to be first oral A?-targeting therapy approved in US and EU, says GlobalData. Given the complex pathophysiology of Alzheimer's disease (AD), developing disease modifying therapies (DMTs) that target different aspects of AD pathology is critical.
ENTOD Pharmaceuticals on Thursday announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.
In a bid to enhance healthcare provisions in the Republic of Belarus, the Pharmaceuticals Holding Company BELPHARMPROM, under the Ministry of Health, has reached out to Indian pharmaceutical companies for collaboration. This move aims to address the demand for essential medicines and explore opportunities for the localization of finished dosage forms (FDF).
The Subject Expert Committee (SEC), that advises the Central drug regulator regarding clinical trials and approvals of drugs, has recommended for grant of permission to Dr Reddy's Laboratories to import and market cancer drug toripalimab 240 mg solution for infusion with waiver of local phase III clinical trial, subject to conditions.